Literature DB >> 22516477

Local allergic rhinitis: concept, pathophysiology, and management.

Carmen Rondón1, Paloma Campo, Alkis Togias, Wytske J Fokkens, Stephen R Durham, Desmond G Powe, Joaquim Mullol, Miguel Blanca.   

Abstract

Local allergic rhinitis (LAR) is a localized nasal allergic response in the absence of systemic atopy characterized by local production of specific IgE (sIgE) antibodies, a T(H)2 pattern of mucosal cell infiltration during natural exposure to aeroallergens, and a positive nasal allergen provocation test response with release of inflammatory mediators (tryptase and eosinophil cationic protein). Although the prevalence remains to be established, a number of patients previously given a diagnosis of nonallergic rhinitis or idiopathic rhinitis are now being classified as having LAR. Culprit allergens responsible include house dust mite, grass and olive pollens, and many others. For the diagnosis of LAR, neither skin prick testing nor determination of the presence of serum sIgE antibodies is useful, and a nasal allergen provocation test is needed to identify the culprit allergen or allergens. In a certain proportion of cases, local sIgE can be detected, and conjunctivitis, asthma, or both can be associated. Whether patients with LAR will have systemic atopy in the future is a matter of debate. Further studies are needed for examine the prevalence of this phenomenon in different areas, to improve the diagnostic methods to better identify these patients, and to develop therapeutic approaches, including the use of immunotherapy. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22516477     DOI: 10.1016/j.jaci.2012.02.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  60 in total

1.  Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes.

Authors:  Alkis Togias; Peter J Gergen; Jack W Hu; Denise C Babineau; Robert A Wood; Robyn T Cohen; Melanie M Makhija; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Andrew H Liu; Emily Wang; Haejin Kim; Carin I Lamm; Leonard B Bacharier; Dinesh Pillai; Steve M Sigelman; James E Gern; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2018-09-11       Impact factor: 10.793

Review 2.  Occupational irritant and allergic rhinitis.

Authors:  Dennis Shusterman
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

Review 3.  Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.

Authors:  Lei Cheng; Jianjun Chen; Qingling Fu; Shaoheng He; Huabin Li; Zheng Liu; Guolin Tan; Zezhang Tao; Dehui Wang; Weiping Wen; Rui Xu; Yu Xu; Qintai Yang; Chonghua Zhang; Gehua Zhang; Ruxin Zhang; Yuan Zhang; Bing Zhou; Dongdong Zhu; Luquan Chen; Xinyan Cui; Yuqin Deng; Zhiqiang Guo; Zhenxiao Huang; Zizhen Huang; Houyong Li; Jingyun Li; Wenting Li; Yanqing Li; Lin Xi; Hongfei Lou; Meiping Lu; Yuhui Ouyang; Wendan Shi; Xiaoyao Tao; Huiqin Tian; Chengshuo Wang; Min Wang; Nan Wang; Xiangdong Wang; Hui Xie; Shaoqing Yu; Renwu Zhao; Ming Zheng; Han Zhou; Luping Zhu; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2018-07       Impact factor: 5.764

4.  An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammation.

Authors:  Sun-Young Nam; Hee-Yun Kim; Jin-Young Min; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

Review 5.  Clinical practice. Allergic rhinitis.

Authors:  Lisa M Wheatley; Alkis Togias
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

6.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 7.  IgE Test in Secretions of Patients with Respiratory Allergy.

Authors:  Carmen Rondón; Ibon Eguíluz-Gracia; Mohamed H Shamji; Janice A Layhadi; María Salas; María José Torres; Paloma Campo
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-13       Impact factor: 4.806

Review 8.  Vaccine development and new attempts of treatment for ragweed allergy.

Authors:  David El-Qutob
Journal:  Ther Adv Vaccines       Date:  2015-03

9.  [Local allergic rhinitis to Alternaria alternata : Evidence for local IgE production exclusively in the nasal mucosa].

Authors:  L Klimek; C Bardenhewer; M Spielhaupter; C Harai; K Becker; O Pfaar
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

10.  Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps.

Authors:  Sonya Marcus; Joseph Schertzer; Lauren T Roland; Sarah K Wise; Joshua M Levy; John M DelGaudio
Journal:  Int Forum Allergy Rhinol       Date:  2019-10-10       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.